Education company diversifies as core learning business slows; health supplement lineup grows to four products
Gyowon Bbalgangpen, best known as an education company, is drawing attention for its push into the children's growth and wellness segment.
The company first entered the space in 2023 with "Kiclap HT042," a health supplement aimed at supporting children's height growth. In 2024, it followed up with "Brainy Eye," a product targeting eye health.
This year, the company launched "Nose Solution" in January, a supplement designed to help improve nasal conditions caused by hypersensitivity reactions. More recently, it released "Brainy Eye+" — an upgraded version of "Brainy Eye" with an added memory-improvement function — continuing to expand its health supplement lineup.
The moves are widely seen as a strategy to offset slowing growth in the company's core education and workbook business. Beyond health supplements, the company is expected to pursue further horizontal expansion into businesses that carry no risk of cannibalizing other Gyowon Group operations.
A company official said growth remains a core value and that various business opportunities are under review.
Meanwhile, the revamped "Brainy Eye+" features figwort extract — an individually recognized functional ingredient approved by the Ministry of Food and Drug Safety — as its key active component for memory improvement. The product may also help reduce eye fatigue. The company said it additionally contains perilla extract with luteolin glycoside (L7DG), which may further support eye fatigue relief.
freiheit@heraldcorp.com
